SOX17 能够使早期结肠直肠腺瘤和癌症的免疫逃避
Norihiro Goto1, Peter M K Westcott1,2, Saori Goto1
1Department of Biology, The David H. Koch Institute for Integrative Cancer Research at MIT, Massachusetts Institute of Technology, Cambridge, MA, USA.
Nature
|February 28, 2024
概括
早期结肠直肠癌 (CRC) 通过上调SOX17来逃避免疫检测. 这种转录因子抑制抗瘤反应,使免疫逃避瘤细胞持续生长.
科学领域:
- 癌症学
- 免疫学
- 分子生物学
背景情况:
- 癌症免疫逃避对于瘤的进展至关重要.
- 早期结肠直肠癌 (CRC) 免疫规避的机制尚不清楚.
- 研究早期的CRC免疫逃避可以揭示新的治疗点.
研究的目的:
- 阐明SOX17在早期结直肠癌发展过程中的免疫逃避中的作用.
- 了解SOX17如何影响瘤微环境和免疫细胞透.
- 确定促进瘤开始和进展的SOX17介导途径.
主要方法:
- 工程 Apc-null,KrasG12D,Trp53-null (AKP) 结肠癌器官用于体外和体内研究.
- 使用全面的转录和染色体分析来评估基因表达变化.
- 研究了SOX17损失对瘤生长,免疫细胞透和干扰素- (IFNγ) 反应的影响.
- 分析了主要组织相容性复合体I类 (MHC- I) 表达和LGR5+与LGR5-瘤细胞群.
主要成果:
- 在早期的CRC有机体中,SOX17在体内显著上调.
- 在体内,SOX17的损失会损害瘤的持续性,并导致CD8+ T细胞的透增加.
- SOX17抑制了瘤细胞对IFNγ的感知和反应,阻碍了抗瘤免疫力.
- 促进SOX17分化为具有减少MHC- I表达的免疫逃避性LGR5瘤细胞.
结论:
- SOX17作为一个关键的转录因子,在早期结肠直肠癌中协调免疫逃避程序.
- 通过抑制抗瘤免疫反应,SOX17促进CRC的发作和进展.
- 向SOX17或其下游途径可能提供增强早期CRC抗瘤免疫力的策略.
更多相关视频
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
10.0K
06:24Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
890
相关概念视频
01:33Pleiotropy
40.4K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
40.4K
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K